Sanara MedTech

About:

Sanara MedTech develop, market, and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings.

Website: https://sanaramedtech.com/

Twitter/X: sanaramedtech

Top Investors: CRG Servicing

Description:

With their focus on improving patient outcomes with evidence-based healing solutions, they develop, market and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings. They are constantly seeking long-term partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Their products are primarily sold in the North American surgical tissue repair and advanced wound care markets.

Total Funding Amount:

$74.1M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Fort Worth, Texas, United States

Founded Date:

1982-01-01

Founders:

Kenneth E. Thorpe

Number of Employees:

101-250

Last Funding Date:

2024-04-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai